Abstract:Objective To develop a superparamagnetic iron oxide nanoparticles ( SPIO ) based on MRI probe specifically targeting human epidermal growth factor receptor 2 (HER2) and explore its value as MRI positive contrast agents in vitro.Methods (1) The superparamagnetic iron oxide ( PS) was obtained by means of classical coprecipitation in polylactic acid solution , then coupled with fluorescein isothiocyanate (FITC) labeled LTVSPYW to develop the targeted probe ( FITC-LTVSPWY-PS).The particle size was measured under transmission electron microscope.Relaxation rate was detected by 3.0 T MR scanner.(2) Climbing films of human breast cancer cell MCF-7 were prepared and incubated with FITC-LTVSPWY-SPIO, then fluorescence distribution was observed under inverted microscope.And distribution of iron particles was confirmed by prussian blue staining.(3) MCF-7 and MDA-MB-231 cells were incubated with FITC-LTVSPWY-SPIO and PS, respectively.MCF-7 incubated with FITC-LTVSPWY-PS were used as experimental group, MCF-7 treated with PS as control group , and cells added with nothing as blank group.There were 3 samples in each group.The MR imaging was performed only once and T 2 WI signal intensity of cells was recorded.The comparison of T 2 signal intensity among groups was conducted by using one-way ANOVA.Results The core and surface size of nanoparticles were (13.9 ±1.6) nm and (122.0 ±5.5) nm respectively.Zeta potential and relaxation rate of the FITC-LTVSPWY-PS were ( -30.7 ±2.2 ) mV and 70.7 m· M-1 · s-1 respectively, and the PS were (28.1 ±2.8) mV and 72.1 m· M-1 · s-1 respectively.The fluorescence could be seen on the surface of MCF-7 cells, and the prussian blue staining showed that FITC-LTVSPWY-PS could specifically target HER 2-positive cells.The low signal on T 2 WI was observed in MCF-7 cells incubated with FITC-LTVSPWY-PS, whereas cells treated with PS and blank group showed equal signals , the T2 values were ( 61.8 ±5.7 ) , ( 101.6 ±2.5 ) and ( 103.5 ±1.9 ) ms respectively.Significant difference existed among these groups ( F =355.698, P <0.05 ).Conclusions The MR targeting probe FITC-LTVSPWY-PS was prepared successfully , its physical characterization and magnetic properties could target the HER 2 highly expressing on the surface of breast cancer cells and meet the need of targeted imaging.It provides an important tool for MR molecular imaging.

Construction of Pepstatin A-Conjugated Ultrasmall SPIONs for Targeted Positive MR Imaging of Epilepsy-Overexpressed P-glycoprotein

A Multimodal Pepstatin A Peptide-Based Nanoagent for the Molecular Imaging of P-Glycoprotein in the Brains of Epilepsy Rats

Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles

Dual-targeting and Excretable Ultrasmall SPIONs for T1-weighted Positive MR Imaging of Intracranial Glioblastoma Cells by Targeting the Lipoprotein Receptor-Related Protein

Engineered Superparamagnetic Iron Oxide Nanoparticles (spions) for Dual-Modality Imaging of Intracranial Glioblastoma Via EGFRvIII Targeting

Dual-targeting and excretable ultrasmall SPIONs for <i>T</i><sub>1</sub>-weighted positive MR imaging of intracranial glioblastoma cells by targeting the lipoprotein receptor-related protein

An electric-field-responsive paramagnetic contrast agent enhances the visualization of epileptic foci in mouse models of drug-resistant epilepsy

Imaging epileptic foci in mouse models via a low-density lipoprotein receptor-related protein-1 targeting strategy

Molecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.

Functionalized Nanocarrier Combined Seizure-Specific Vector with P-glycoprotein Modulation Property for Antiepileptic Drug Delivery.

Guiding Epilepsy Surgery with an LRP1-Targeted SPECT/SERRS Dual-Mode Imaging Probe

Targeted nanotheranostics for the treatment of epilepsy through in vivo hijacking of locally activated macrophages

ROS/Electro Dual-Reactive Nanogel for Targeting Epileptic Foci to Remodel Aberrant Circuits and Inflammatory Microenvironment

Preparation of MRI molecular probe targeting human epidermal growth factor receptor 2 and the ;preliminary study of breast cancer cell in vitro

Citric acid coated ultrasmall superparamagnetic iron oxide nanoparticles conjugated with lactoferrin for targeted negative MR imaging of glioma

Development of Peptide Conjugated Superparamagnetic Iron Oxide (SPIO) Nanoparticles for Targeted MR Imaging and Therapy of Pancreatic Cancer

Synthesis and Evaluation of TSPO-targeting Radioligand [18F]F-TFQC for PET Neuroimaging in Epileptic Rats

Guiding Epilepsy Surgery by Intraoperatively Visualizing Proinflammatory Microglia via a Ratiometric Surface-Enhanced Raman Scattering Nanosensor

Two-order Targeted Brain Tumor Imaging by Using an Optical/paramagnetic Nanoprobe Across the Blood Brain Barrier.

Prostate Cancer Targeted MRI Nanoprobe Based on Superparamagnetic Iron Oxide and Copolymer of Poly(ethylene Glycol) and Polyethyleneimin

Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures